We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PET Impact Found Consistent Across Cancer Types and Imaging Indications

By HospiMedica International staff writers
Posted on 02 Dec 2008
New data provided by positron emission tomography (PET) imaging were found to affect how clinicians manage their cancer patients' care regardless of the cancer type and reason for ordering this imaging scan, according to results from a U.S. More...
PET registry.

The findings, from the [U.S.] National Oncologic PET Registry (NOPR; Philadelphia, PA, USA), was published online November 7, 2008, in the Journal of Nuclear Medicine (JNM). Earlier in 2008, the study authors reported in the Journal of Clinical Oncology (JCO) aggregate data contributed to the NOPR during year one of operation that demonstrated clinicians changed the intended care of more than one in three cancer patients as the result of PET scan findings.

After two years of operation, with nearly twice the data for analysis, the researchers found the impact of PET to be noticeably consistent for a wide range of cancers and indications. For this follow up NOPR study, researchers analyzed data for 40,863 PET studies performed at 1,368 facilities participating in the NOPR in the United States during the registry's first two years of operation. The impact of PET was assessed for 18 cancer types in patients with pathologically confirmed cancer and for indication for testing that included initial cancer staging (14,365 scans), restaging (14,584 scans), or detection of suspected cancer recurrence (11,914 scans).

"For the purposes of guiding clinical practice and shaping coverage policy, it is important to determine the relative effects of PET for different cancer types and indications for testing," said Bruce Hillner, M.D., lead author for the study, and professor and eminent scholar in the department of internal medicine at Virginia Commonwealth University. "These results strongly indicate the utility of PET for managing cancer patient care across a broad spectrum of cancer types and imaging indications."

The National Oncologic PET Registry (NOPR) is a collaboration of the American College of Radiology Imaging Network (ACRIN), the American College of Radiology (ACR; Restin, VA, USA), and the Academy of Molecular Imaging (AMI; Los Angeles, CA, USA), to ensure access to U.S. Medicare reimbursement for certain types of PET scans.

Related Links:
National Oncologic PET Registry
American College of Radiology
ACR Imaging Network
Academy of Molecular Imaging



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Monitoring System
AlarmSense
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Aliya EX Generator for surgical ablation of soft tissue (Photo courtesy of Galvanize Therapeutics)

Next-Generation PEF System Delivers Larger Ablation Zones for Soft-Tissue Procedures

Interventional teams often need soft-tissue ablation options that can be performed percutaneously or endoscopically while minimizing collateral injury and preserving procedural workflow.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.